How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?

Abstract excerpt

Many genetic variants in drug metabolizing enzymes and transporters have been shown to be relevant for treating psychiatric disorders. Associations are strong enough to feature on drug labels and for prescribing guidelines based on such data. A range of commercial tests are available; however, there is variability in included genetic variants, methodology, and interpretation. We herein provide relevant background...

Topics

Join the communities discussing this publication.

• Bipolar Disorder and Treatment
• Pharmacogenetics and Drug Metabolism
• Pharmacological Effects and Toxicity Studies